Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1171-1176

  Ohsaka, Akimichi ^a   Hirota Komatsu, Satoko ^a   Shibata, Miki ^a   Komatsu, Norio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Megakaryocytic differentiation; Neuropilin 1; Receptor complex; VEGF; VEGFR 2

Indexed keywords

MESSENGER RNA; NEUROPILIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOPOIETIN; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 2;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN; UPREGULATION;

CELL DIFFERENTIATION; CELL LINE; HUMANS; MEGAKARYOCYTES; NEUROPILIN-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70450270664     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.110     Document Type: Article

References (28)

1. Ferrara N., Gerber H.-P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
2. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9 (2003) 702-712
3. Gerber H.P., and Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J. Mol. Med. 81 (2003) 20-31
4. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
5. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., and Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
6. Bautz F., Rafii S., Kanz L., and Möhle R. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp. Hematol. 28 (2000) 700-706
7. Gerber H.P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., Hong K., Marsters J.C., and Ferrara N. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
8. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115 (2005) 3339-3347
9. Möhle R., Green D., Moore M.A., Nachman R.L., and Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA 94 (1997) 663-668
10. Bobik R., Hong Y., Breier G., Martin J.F., and Erusalimsky J.D. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors. FEBS Lett. 423 (1998) 10-14
11. Kirito K., Fox N., Komatsu N., and Kaushansky K. Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha. Blood 105 (2005) 4258-4263
12. Neufeld G., Cohen T., Shraga N., Lange T., Kessler O., and Herzog Y. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12 (2002) 13-19
13. Kitsukawa T., Shimizu M., Sanbo M., Hirata T., Taniguchi M., Bekku Y., Yagi T., and Fujisawa H. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19 (1997) 995-1005
14. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., and Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 126 (1999) 4895-4902
15. Soker S., Takashima S., Miao H.Q., Neufeld G., and Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92 (1998) 735-745
16. Ohsaka A., Hirota-Komatsu S., Shibata M., Ezaki J., Shinohara F., and Yoshida T. Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cells. Biochem. Biophys. Res. Commun. 368 (2008) 543-549
17. Komatsu N., Kunitama M., Yamada M., Hagiwara T., Kato T., Miyazaki H., Eguchi M., Yamamoto M., and Miura Y. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 87 (1996) 4552-4560
18. Miao H.Q., Soker S., Feiner L., Alonso J.L., Raper J.A., and Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146 (1999) 233-242
19. Casella I., Feccia T., Chelucci C., Samoggia P., Castelli G., Guerriero R., Parolini I., Petrucci E., Pelosi E., Morsilli O., Gabbianelli M., Testa U., and Peschle C. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 101 (2003) 1316-1323
20. Ziegler B.L., Valtieri M., Porada G.A., De Maria R., Müller R., Masella B., Gabbianelli M., Casella I., Pelosi E., Bock T., Zanjani E.D., and Peschle C. KDR receptor: a key marker defining hematopoietic stem cells. Science 285 (1999) 1553-1558
21. Coppola S., Narciso L., Feccia T., Bonci D., Calabrò L., Morsilli O., Gabbianelli M., De Maria R., Testa U., and Peschle C. Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line. Cell Death Differ. 13 (2006) 61-74
22. Tordjman R., Ortéga N., Coulombel L., Plouët J., Roméo P.H., and Lemarchandel V. Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells?. Blood 94 (1999) 2301-2309
23. Yamada Y., Oike Y., Ogawa H., Ito Y., Fujisawa H., Suda T., and Takakura N. Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood 101 (2003) 1801-1809
24. Jia H., Bagherzadeh A., Hartzoulakis B., Jarvis A., Löhr M., Shaikh S., Aqil R., Cheng L., Tickner M., Esposito D., Harris R., Driscoll P.C., Selwood D.L., and Zachary I.C. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J. Biol. Chem. 281 (2006) 13493-13502
25. Soker S., Miao H.Q., Nomi M., Takashima S., and Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell. Biochem. 85 (2002) 357-368
26. Whitaker G.B., Limberg B.J., and Rosenbaum J.S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem. 276 (2001) 25520-25531
27. Prahst C., Héroult M., Lanahan A.A., Uziel N., Kessler O., Shraga-Heled N., Simons M., Neufeld G., and Augustin H.G. Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J. Biol. Chem. 283 (2008) 25110-25114
28. Kirito K., and Kaushansky K. Thrombopoietin stimulates vascular endothelial cell growth factor (VEGF) production in hematopoietic stem cells. Cell Cycle 4 (2005) 1729-1731